Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2026-03-01 @ 6:00 AM
Study NCT ID:
NCT04003220
Status:
UNKNOWN
Last Update Posted:
2022-11-28
First Post:
2019-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
Sponsor:
University Hospital, Bordeaux
Organization:
Study Overview
Official Title:
Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
Status:
UNKNOWN
Status Verified Date:
2022-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ICTUS
Brief Summary:
It is a translational research study with mechanistical objectives and including biological samples of patients with thrombocytopenia
Detailed Description:
This study is a prospective study to collect blood, bone marrow and hair bulb from patients with thrombocytopenia, to better understand the mechanism of idiopathic chronic thrombocytopenia of undetermined significance (ICTUS)
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: